期刊文献+

载脂蛋白C3研究新进展 被引量:4

New advances in apolipoprotein C3
下载PDF
导出
摘要 载脂蛋白C3(apolipoprotein C3,APOC3)是一种水溶性低分子蛋白质,主要分布在血浆高密度脂蛋白、极低密度脂蛋白、乳糜微粒和低密度脂蛋白中。新近研究表明,APOC3是一个多功能蛋白质,是脂质代谢的重要调控因子,与高甘油三酯血症和心血管疾病发病相关,是心血管疾病进展的重要预测因子。APOC3在动脉粥样硬化和糖尿病发展进程中起到重要的作用。因此,调控APOC3水平可能是控制患者脂质代谢异常和治疗心血管疾病的重要策略。
出处 《生理科学进展》 CAS CSCD 北大核心 2018年第3期202-206,共5页 Progress in Physiological Sciences
基金 国家自然基金(81570408)资助课题
  • 相关文献

参考文献3

二级参考文献51

  • 1Grundy SM, Brewer HB, Cleeman JI, et al. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Circulation, 2004, 109 : 433- 438.
  • 2Pollin TI, Damcott CM, Shen H, et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science, 2008, 322 : 1702 - 1705.
  • 3Sacks FM, Alaupovic P, Moye LA, et al. VLDL, apolipoproteins B, C III, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation, 2000, 102 : 1886- 1892.
  • 4Chan DC, Nguyen MN, Watts GF, et al. Plasma apolipoprotein c-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. J Clin Endocrinol Metab, 2008, 93 : 557 - 564.
  • 5Kawakami A, Aikawa M, Nitta N, et al. Apolipoprotein C m-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol, 2007, 27 : 219 -225.
  • 6Kawakami A, Osaka M, Tani M, et al. Apolipoprotein C III links hyperlipidemia with vascular endothelial cell dysfunction. Circulation, 2008,118:731 -742.
  • 7Nguyen MN, Chan DC, Dwyer KP, et al. Use of intralipid for kinetic analysis of HDL apoC-III : evidence for a homogeneous kinetic pool of apoC-III in plasma. J Lipid Res, 2006, 47 : 1274 - 1280.
  • 8Chan DC, Watts GF, Ng TW,et al. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Eur J Clin Invest, 2008, 38 : 743-751.
  • 9Chan DC, Watts GF, Ooi EM, et al. Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome. Arterioscler Thromb Vasc Biol, 2008, 28 : 1831 - 1837.
  • 10Third report of the national cholesterol education (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ ) [J]. Circulation,2002,106 : 3143-- 3421.

共引文献11

同被引文献30

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部